1. Dual antiplatelet therapy with 3rd generation P2Y12 inhibitors in STEMI patients: impact of Body Mass Index on high on-treatment platelet reactivity. (14th October 2021) Authors: Scudiero, F; Canonico, M E; Sanna, G D; Saba, P G; Esposito, G; Parodi, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of PCSK9-Inhibitors in the real-world: data from a clinical registry. (25th November 2020) Authors: Saba, P.S; Murgia, A; Gazale, E; Terrosu, P; Sanna, G.D; Parodi, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Issue 12 (6th April 2005) Authors: Parodi, G; Memisha, G; Valenti, R; Trapani, M; Migliorini, A; Santoro, G M; Antoniucci, D Journal: Heart Issue: Volume 91:Issue 12(2005) Page Start: 1541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hyperthyroidism in Takotsubo syndrome: prevalence, clinical features and long-term outcomes. (25th November 2020) Authors: Scudiero, F; Arcari, L; Silverio, A; Citro, R; Bossone, E; Autore, C; Muraca, I; Chinati, P; Sanna, G; Piti, A; Parodi, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of smoking habit on baseline and on-treatment platelet reactivity in STEMI patients treated with 3rd generation P2Y12. (14th October 2021) Authors: Canonico, M E; Scudiero, F; Sanna, G D; Siciliano, R; Guarino, S; Saba, P S; Esposito, G; Parodi, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. (3rd October 2022) Authors: Centore, M; Silverio, A; Scudiero, F; Di Maio, M; Muraca, I; Dossi, F; Petrini, F; Brenca, D; Maiellaro, F; Attisano, T; Parodi, G; Musumeci, G; Galasso, G Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Left bundle branch block and ventricular dysfunction: the importance of QRS duration over strict morphological criteria; data from the RECOrd-LBBB registry. (3rd October 2022) Authors: Sanna, G D; Privitera, I; Carta, P; Moccia, E; Raccis, M; Canonico, M E; Scudiero, F; Casu, G; Parodi, G Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. M-health and telemedicine: are people ready for the future? A real-world survey. (25th November 2020) Authors: Dossi, F; Marini, A; Sanna, G.D; Saba, P.S; Parodi, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Not-high before-treatment platelet reactivity in patients with STEMI:prevalence, clinical characteristics, response to therapy and outcomes. (14th October 2021) Authors: Canonico, M E; Sanna, G D; Siciliano, R; Guarino, S; Bellandi, B; Scudiero, F; Saba, P S; Esposito, G; Alexopoulos, D; Parodi, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Orodispersible ticagrelor use in acute coronary syndrome patients: the Ticagrelor Administered as Standard Tablet or orodispersiblE foRmulation (TASTER) Study. (25th November 2020) Authors: Parodi, G; Talanas, G; Mura, E; Corda, G; Dossi, F; Canonico, M.E; Guarino, S; Nusdeo, G; Franca, P; Raccis, M; Pisano, M; Sanna, G.D; Saba, P.S Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗